Novavax hopes to negotiate a new agreement with Gavi to ensure its COVID-19 vaccine and other pipeline vaccines can be distributed across the world, after having terminated its prior agreement over a procurement spat this week, a Novavax spokesperson told Inside Health Policy. Novavax announced Monday (Nov. 21) it was ending an Advance Purchase Agreement with Gavi, the Vaccine Alliance, that would have delivered doses of Novavax’s COVID-19 vaccine to low- and middle-income countries, because Gavi didn’t follow...